| Literature DB >> 30909936 |
Rocío Checa1, Luis Eusebio Fidalgo2, Ana Montoya1, Ana María López2, Juan Pedro Barrera1, Rosa Gálvez1, Sara Sánchez de la Nieta1, Valentina Marino1, Juliana Sarquis1, Guadalupe Miró3.
Abstract
BACKGROUND: While in Europe Babesia canis has been traditionally held responsible for canine piroplasmosis, Babesia microti-like piroplasm (Bml) infection is being ever more observed in dogs, with the first clinical cases reported in northwestern Spain. This study examines the epidemiological role of healthy dogs living in endemic areas of Bml infection in Spain. The data obtained were used to describe the clinical status and map the geographical distribution of Bml infection in healthy dogs in northwestern Spain.Entities:
Keywords: Babesia canis; Babesia microti-like piroplasm; Canine piroplasmosis; Healthy dog carriers; Northwestern Spain
Mesh:
Year: 2019 PMID: 30909936 PMCID: PMC6434893 DOI: 10.1186/s13071-019-3371-5
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Sampling sites in northwestern Spain
Fig. 2Geographical distribution of Babesia spp. infection in healthy dog carriers in northwestern Spain (Galicia). Stars indicate co-infection with B. canis and Bml
Epidemiological variables recorded in 114 Bml-infected healthy dogs (PCR and sequencing confirmed)
| Variable |
| Positive Bml (%) |
| |||
|---|---|---|---|---|---|---|
| Dog population | Hunting dog | 333 | 85 (25.5)* | 57.429 | 2 | ≤0.0001 |
| Pet | 212 | 5 (2.4) | ||||
| Stray dog | 211 | 24 (11.4) | ||||
| Study area | A Coruña | 285 | 99 (34.7)* | 139,734 | 3 | ≤0.0001 |
| Lugo | 165 | 6 (3.6) | ||||
| Ourense | 136 | 0 | ||||
| Pontevedra | 170 | 9 (5.3) | ||||
| Breed | Crossbreed | 371 | 63 (17) | 2016 | 1 | 0.156 |
| Pure breed | 377 | 50 (13.3) | ||||
| Age (years) | < 3 | 202 | 27 (13.4) | 0.885 | 2 | 0.642 |
| 3–5 | 248 | 41 (16.5) | ||||
| >5 | 264 | 41 (15.5) | ||||
| Size (kg) | ≤5 | 27 | 5 (18.5) | 23.876 | 3 | ≤0.0001 |
| >5 ≤ 10 | 110 | 25 (22.7)* | ||||
| > 10 ≤ 25 | 333 | 61(18.3)* | ||||
| ≥25 | 228 | 13 (5.7) | ||||
| Sex | Non-neutered male | 255 | 54 (21.2)* | 9.871 | 3 | 0.02 |
| Neutered male | 66 | 5 (7.6) | ||||
| Non-sterilized female | 235 | 40 (17) | ||||
| Sterilized female | 78 | 8 (10.3) | ||||
| Habitat | House with garden | 142 | 1 (0.7) | 66.180 | 4 | ≤0.0001 |
| Flat | 62 | 3 (4.8) | ||||
| Kennel | 316 | 85 (26.9)* | ||||
| Farm | 21 | 1 (4.8) | ||||
| Shelter | 211 | 24 (11.4) | ||||
| Fox-hunting | Yes | 140 | 44 (31.4)* | 10.974 | 1 | 0.001 |
| No | 152 | 23 (15.1) | ||||
| Ticks | Yes | 42 | 10 (23.8) | 1.988 | 1 | 0.165 |
| No | 607 | 95 (15.7) | ||||
| Ectoparasiticides | Yes | 601 | 99 (16.5) | 0.231 | 1 | 0.631 |
| No | 75 | 14 (18.7) | ||||
| Clinical signsa | Presence | 92 | 7 (7.6) | 4.709 | 1 | 0.03 |
| Absence | 657 | 107 (16.3)* | ||||
| Body condition | Thin | 93 | 26 (28)* | 20.767 | 2 | ≤0.0001 |
| Normal | 463 | 83 (17.9) | ||||
| Overweight | 85 | 2 (2.4) | ||||
* Significant differences observed
aSome clinical signs observed but not suggestive of acute canine piroplasmosis
Fig. 3Decision tree model of Bml infection in the studied population. The decision tree model consists of predictors chosen according to their statistical significance, thereby allowing the detection of interactions with the previously selected variable (PCR-confirmed Bml-infected dogs). There are six terminal nodes that show a higher risk of infection with Bml according to the study area, dog population studied, age (years) and habitat (independent variables). Nodes 7 and 8 indicate a higher risk of Bml infection and nodes 4, 6, 9 and 10 a lower risk of Bml infection
Clinicopathological findings in 51 Bml-infected healthy dogs compared to Bml-infected sick dogs
| Blood parameter (reference interval) | Group |
| Mean ± SD | 95% CI | Percentile | |||
|---|---|---|---|---|---|---|---|---|
| 25th | 50th | 75th | ||||||
| Erythrocytes (5.50–8.50) × 106/µl | Healthy | 51 | 5.21 ± 1.20 | 4.87–5.55 | 4.33 | 5.66 | 6.05 | ≤0.0001 |
| Sicka | 72 | 3.28 ± 1.63 | 2.89–3.66 | 2.16 | 2.77 | 4.32 | ||
| Haematocrit (37.00–55.0)% | Healthy | 51 | 42.80 ± 11.13 | 39.67–45.93 | 34.90 | 43.40 | 49.30 | ≤0.0001 |
| Sicka | 72 | 27.13 ± 11.91 | 24.32–29.92 | 18.60 | 23.45 | 36.20 | ||
| Haemoglobin (12.00–18.00) g/dl | Healthy | 51 | 12.01 ± 2.83 | 11.21–12.80 | 9.80 | 12.70 | 13.90 | ≤0.0001 |
| Sicka | 72 | 7.76 ± 3.75 | 6.87–8.64 | 5.00 | 6.50 | 10.20 | ||
| MCV (60.00–76.00) fl | Healthy | 51 | 80.89 ± 8.85 | 78.40–83.38 | 75.80 | 82.20 | 86.80 | 0.495 |
| Sicka | 71 | 82.42 (8.25) | 80.46–84.38 | 76.00 | 81.50 | 87.30 | ||
| MCHC (32.00–36.00) g/dl | Healthy | 51 | 28.80 ± 3.08 | 27.93–29.67 | 26.90 | 28.50 | 29.80 | 0.456 |
| Sicka | 71 | 28.26 ± 2.61 | 27.64–28.88 | 26.70 | 28.20 | 29.70 | ||
| Leukocytes (6–17) × 103/µl | Healthy | 51 | 11.55 ± 3.86 | 10.46–12.63 | 9.09 | 10.71 | 13.87 | 0.006 |
| Sicka | 72 | 14.42 ± 6.26 | 12.95–15.89 | 10.50 | 13.32 | 17.10 | ||
| Platelets (200–500) × 103/µl | Healthy | 51 | 207.70 ± 105.76 | 177.96–237.45 | 147.00 | 192.00 | 251.00 | 0.021 |
| Sicka | 59 | 158.46 ± 90.35 | 134.90–182.00 | 90.00 | 165.00 | 218.00 | ||
| Urea (21–59) mg/dl | Healthy | 51 | 41.01 ± 28.41 | 33.02–49.01 | 28.00 | 35.00 | 43.00 | 0.384 |
| Sicka | 71 | 60.49 ± 90.34 | 39.11–81.88 | 28.00 | 37.00 | 47.00 | ||
| Creatinine (0.5–1.5) mg/dl | Healthy | 51 | 0.70 ± 0.35 | 0.60–0.80 | 0.50 | 0.60 | 0.80 | 0.255 |
| Sicka | 71 | 0.95 ± 1.35 | 0.63–1.27 | 28.00 | 37.00 | 47.00 | ||
| Total proteins (4.8–7.8) g/dl | Healthy | 51 | 7.90 ± 1.06 | 7.60–8.20 | 7.20 | 7.80 | 8.30 | ≤0.0001 |
| Sicka | 71 | 6.93 ± 1.09 | 6.67–7.19 | 6.20 | 6.90 | 7.80 | ||
| ALT (26–89) UI/l | Healthy | 51 | 51.76 ± 56.50 | 35.90–67.65 | 26.00 | 37.00 | 55.00 | 0.006 |
| Sicka | 70 | 48.34 ± 110.43 | 22.01–74.67 | 20.00 | 28.00 | 42.00 | ||
| AST (16–89) UI/l | Healthy | 51 | 42 ± 13.82 | 37.99–46.01 | 32.00 | 39.00 | 48.00 | – |
| SDMA (0–14) µ/dl | Healthy | 48 | 15.42 ± 5.41 | 13.84–16.99 | 12.00 | 15.00 | 18.00 | – |
Abbreviations: CI, confidence interval; SD, standard deviation
aData reported previously by Miró et al. [9]